Literature DB >> 16021411

[Radical prostatectomy for men aged <56 years with prostate cancer. Cost of illness analysis].

K Herkommer1, T A Fuchs, R E Hautmann, B G Volkmer.   

Abstract

BACKGROUND: Prostate cancer is the most frequent malignant tumor in men; 10% of the patients are younger than 56 years at the time of diagnosis and are usually still working. The aim of this study was to evaluate the costs of the disease within the first 3 years from diagnosis.
MATERIAL AND METHODS: A total of 200 patients (aged <56 years) after radical prostatectomy with curative intent were asked for their social status, professional training and job before and after radical prostatectomy, disablement, length of hospital stay, rehabilitation, early retirement, part-time retirement, retraining program, job-creating measures, and working conditions after radical prostatectomy.
RESULTS: Of the 200 patients queried, 177 (88.5%) answered the questionnaire. Prior to the radical prostatectomy 163 patients were employed. They were off work for a mean time of 104.4 days, 83.4% of them received inpatient rehabilitation treatment after surgery, 121 (74.2%) regained full fitness for work, 9 (5.5%) retired on grounds of age, 21 (12.9%) had an early retirement because of the disease, and 12 (7.4%) became unemployed. Within the first 3 years after diagnosis, the following mean costs had to be paid: 465.79 <euro> by the patient, 6569.76 <euro> by the employer, 16,356.96 <euro> by the health insurance, 13,304.88 <euro> by the pension scheme, and 3912.57 <euro> by the employment office.
CONCLUSION: The main costs in patients with prostate cancer and radical prostatectomy have to been paid by the health insurance scheme and the pension scheme; 74.3% of the patients regained full fitness for work. The time until reintegration into work was correlated to the extent of physical labor.

Entities:  

Mesh:

Year:  2005        PMID: 16021411     DOI: 10.1007/s00120-005-0868-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  11 in total

1.  Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer.

Authors:  J P Ciezki; E A Klein; K W Angermeier; J Ulchaker; C D Zippe; D A Wilkinson
Journal:  Urology       Date:  2000-01       Impact factor: 2.649

2.  The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques.

Authors:  Yair Lotan; Jeffrey A Cadeddu; Matthew T Gettman
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

3.  Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database.

Authors:  D F Penson; W H Schonfeld; S C Flanders; C J Henke; K L Warolin; P R Carroll; M S Litwin
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

4.  Charge and length of hospital stay analysis of radical retropubic prostatectomy and transperineal prostate brachytherapy.

Authors:  T T Wagner; D Young; R R Bahnson
Journal:  J Urol       Date:  1999-04       Impact factor: 7.450

5.  Perioperative costs and charges of prostate brachytherapy and prostatectomy.

Authors:  Antoine A Makhlouf; James C Boyd; Terrence N Chapman; Dan Theodorescu
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

6.  A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.

Authors:  J Brandeis; C L Pashos; J M Henning; M S Litwin
Journal:  Cancer       Date:  2000-10-15       Impact factor: 6.860

7.  Making ends meet: a cost comparison of laparoscopic and open radical retropubic prostatectomy.

Authors:  Richard E Link; Li-Ming Su; Sam B Bhayani; Christian P Pavlovich
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

8.  Adenocarcinoma of the prostate: an expensive way to die.

Authors:  N Y Piper; L Kusada; R Lance; J Foley; J Moul; T Seay
Journal:  Prostate Cancer Prostatic Dis       Date:  2002       Impact factor: 5.554

Review 9.  Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.

Authors:  Inger Norderhaug; Olav Dahl; Per A Høisaeter; Reino Heikkilä; Olbjørn Klepp; Dag Rune Olsen; Ivar S Kristiansen; Håkon Waehre; Truls E Bjerklund Johansen
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

10.  Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer.

Authors:  Jeffrey H Burkhardt; Mark S Litwin; Christopher M Rose; Roy J Correa; Jonathan H Sunshine; Christopher Hogan; James A Hayman
Journal:  J Clin Oncol       Date:  2002-06-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.